Clinical Image: Bilateral black eyes (raccoon's eyes) in AL amyloidosis

Abstract

therapy in juvenile systemic lupus erythematosus: prospective vali-dation of the disease activity core set. Arthritis Rheum 2005;52:2854–64.3. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH,and the Committee on Prognosis Studies in SLE. Derivation of theSLEDAI: a disease activity index for lupus patients. ArthritisRheum 1992;35:630–40.4. Liang MH, Socher SA, Larson MG, Schur PH. Reliability andvalidity of six systems for the clinical assessment of disease activityin systemic lupus erythematosus. Arthritis Rheum 1989;32:1107–18.5. Vitali C, Bencivelli W, Isenberg DA, Smolen JS, Snaith ML, SciutoM, et al, and The European Consensus Study Group for DiseaseActivity in SLE. Disease activity in systemic lupus erythematosus:report of the Consensus Study Group of the European Workshopfor Rheumatology Research. II. Identification of the variablesindicative of disease activity and their use in the development of anactivity score. Clin Exp Rheumatol 1992;10:541–7.6. Ruperto N, Ravelli A, Murray KJ, Lovell DJ, Andersson-Gare B,Feldman BM, et al, for the Paediatric Rheumatology InternationalTrials Organisation (PRINTO) and the Pediatric RheumatologyCollaborative Study Group (PRCSG). Preliminary core sets ofmeasures for disease activity and damage assessment in juvenilesystemic lupus erythematosus and juvenile dermatomyositis. Rheu-matology (Oxford) 2003;42:1452–9.7. Ruperto N, Ravelli A, Oliveira S, Alessio M, Mihaylova D, Pasic S,et al, for the Pediatric Rheumatology International Trials Or-ganization (PRINTO) and the Pediatric Rheumatology Collabora-tive Study Group (PRCSG). The Pediatric Rheumatology Inter-national Trials Organization/American College of Rheumatologyprovisional criteria for the evaluation of response to therapy injuvenile systemic lupus erythematosus: prospective validationof the definition of improvement. Arthritis Rheum2006;55:355–63.